A citation-based method for searching scientific literature

Aliaksandr A Yarmishyn, Afeez Adekunle Ishola, Chieh-Yu Chen, Nalini Devi Verusingam, Vimalan Rengganaten, Habeebat Aderonke Mustapha, Hao-Kai Chuang, Yuan-Chi Teng, Van Long Phung, Po-Kuei Hsu, Wen-Chang Lin, Hsin-I Ma, Shih-Hwa Chiou, Mong-Lien Wang. Cancers (Basel) 2022
Times Cited: 4







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?
Leonardo Salmena, Laura Poliseno, Yvonne Tay, Lev Kats, Pier Paolo Pandolfi. Cell 2011
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Circular RNAs are abundant, conserved, and associated with ALU repeats.
William R Jeck, Jessica A Sorrentino, Kai Wang, Michael K Slevin, Christin E Burd, Jinze Liu, William F Marzluff, Norman E Sharpless. RNA 2013
50

Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-κB/bone remodeling factors signaling.
Yingru Xu, Shuxia Zhang, Xinyi Liao, Man Li, Suwen Chen, Xincheng Li, Xingui Wu, Meisongzhu Yang, Miaoling Tang, Yameng Hu,[...]. Mol Cancer 2021
16
50

Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs.
Qiupeng Zheng, Chunyang Bao, Weijie Guo, Shuyi Li, Jie Chen, Bing Chen, Yanting Luo, Dongbin Lyu, Yan Li, Guohai Shi,[...]. Nat Commun 2016
50

The growth of siRNA-based therapeutics: Updated clinical studies.
M May Zhang, Raman Bahal, Theodore P Rasmussen, José E Manautou, Xiao-Bo Zhong. Biochem Pharmacol 2021
96
25

RNAi-based therapeutics and tumor targeted delivery in cancer.
Goknur Kara, George A Calin, Bulent Ozpolat. Adv Drug Deliv Rev 2022
24
25




Most mammalian mRNAs are conserved targets of microRNAs.
Robin C Friedman, Kyle Kai-How Farh, Christopher B Burge, David P Bartel. Genome Res 2009
25


Glucose transporters in cancer metabolism.
Kehinde Adekola, Steven T Rosen, Mala Shanmugam. Curr Opin Oncol 2012
215
25

Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
L Mastroberardino, B Spindler, R Pfeiffer, P J Skelly, J Loffing, C B Shoemaker, F Verrey. Nature 1998
438
25

MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro.
Ya Bin Wei, Philippe A Melas, J Carlos Villaescusa, Jia Jia Liu, Ning Xu, Søren Hofman Christiansen, Heidi Elbrønd-Bek, David Paul Drucker Woldbye, Gregers Wegener, Aleksander A Mathé,[...]. Int J Neuropsychopharmacol 2016
20
25

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.
George Adrian Calin, Cinzia Sevignani, Calin Dan Dumitru, Terry Hyslop, Evan Noch, Sai Yendamuri, Masayoshi Shimizu, Sashi Rattan, Florencia Bullrich, Massimo Negrini,[...]. Proc Natl Acad Sci U S A 2004
25

Solute carrier proteins and c-Myc: a strong connection in cancer progression.
Suman Panda, Nilanjan Banerjee, Subhrangsu Chatterjee. Drug Discov Today 2020
17
25

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.
Jacob O'Brien, Heyam Hayder, Yara Zayed, Chun Peng. Front Endocrinol (Lausanne) 2018
25

MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells.
Guillaume Dalmasso, Hang Thi Thu Nguyen, Yutao Yan, Hamed Laroui, Moiz A Charania, Tracy S Obertone, Shanthi V Sitaraman, Didier Merlin. Am J Physiol Gastrointest Liver Physiol 2011
49
25


Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy-Modulators of Cellular Entry or Pharmacokinetics?
Karin Brecht, Anima Magdalena Schäfer, Henriette E Meyer Zu Schwabedissen. Cancers (Basel) 2020
11
25

The Potential for microRNA Therapeutics and Clinical Research.
Johora Hanna, Gazi S Hossain, Jannet Kocerha. Front Genet 2019
364
25

Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs.
Jacek Krol, Volker Busskamp, Ilona Markiewicz, Michael B Stadler, Sebastian Ribi, Jens Richter, Jens Duebel, Silvia Bicker, Hans Jörg Fehling, Dirk Schübeler,[...]. Cell 2010
355
25

Structural biology of solute carrier (SLC) membrane transport proteins.
Xiaoyun Bai, Trevor F Moraes, Reinhart A F Reithmeier. Mol Membr Biol 2017
80
25

The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29.
James D Young, Sylvia Y M Yao, Jocelyn M Baldwin, Carol E Cass, Stephen A Baldwin. Mol Aspects Med 2013
215
25


Challenges identifying efficacious miRNA therapeutics for cancer.
Meirav Segal, Frank J Slack. Expert Opin Drug Discov 2020
50
25

Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation.
Khalid Rashid, Aqeel Ahmad, Li Liang, Mengling Liu, Yuehong Cui, Tianshu Liu. Drug Discov Today 2021
6
25

In vivo fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy.
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Neelu Batra, Michelle M L Tran, Jing-Xin Qiu, Theodore Wun, Primo N Lara, Xiang Hu, Ai-Xi Yu,[...]. Theranostics 2021
8
25

Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells.
Dianke Yu, William H Tolleson, Bridgett Knox, Yaqiong Jin, Lei Guo, Yongli Guo, Susan A Kadlubar, Baitang Ning. Biochem Pharmacol 2015
21
25

MicroRNA-223 Expression is Upregulated in Insulin Resistant Human Adipose Tissue.
Tung-Yueh Chuang, Hsiao-Li Wu, Chen-Chun Chen, Gloria Mabel Gamboa, Lawrence C Layman, Michael P Diamond, Ricardo Azziz, Yen-Hao Chen. J Diabetes Res 2015
66
25

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.
Wen Jess Li, Yunfei Wang, Ruifang Liu, Andrea L Kasinski, Haifa Shen, Frank J Slack, Dean G Tang. Front Cell Dev Biol 2021
30
25

Supply and demand: Cellular nutrient uptake and exchange in cancer.
Vasileios Papalazarou, Oliver D K Maddocks. Mol Cell 2021
5
25

Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics.
Shan Yu, Yanshuang Wu, Chunlong Li, Zhaowei Qu, Ge Lou, Xiaorong Guo, Jingjing Ji, Nan Li, Mian Guo, Maomao Zhang,[...]. Sci Rep 2020
27
25

The role of MicroRNAs in human cancer.
Yong Peng, Carlo M Croce. Signal Transduct Target Ther 2016
25

Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer.
Hongliang Li, Shuxian Chen, Jia Liu, Xiaopeng Guo, Xudong Xiang, Tianqi Dong, Pengzhan Ran, Qian Li, Bei Zhu, Xiyu Zhang,[...]. Biochem Biophys Res Commun 2018
50
25

miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants.
Anne Baudry, Sophie Mouillet-Richard, Benoît Schneider, Jean-Marie Launay, Odile Kellermann. Science 2010
340
25


Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth.
Mariafrancesca Scalise, Lorena Pochini, Michele Galluccio, Lara Console, Cesare Indiveri. Front Oncol 2017
100
25

CD46 Activation Regulates miR-150-Mediated Control of GLUT1 Expression and Cytokine Secretion in Human CD4+ T Cells.
Ben C King, Jonathan L S Esguerra, Ewelina Golec, Lena Eliasson, Claudia Kemper, Anna M Blom. J Immunol 2016
40
25

Comparison of human solute carriers.
Avner Schlessinger, Pär Matsson, James E Shima, Ursula Pieper, Sook Wah Yee, Libusha Kelly, Leonard Apeltsin, Robert M Stroud, Thomas E Ferrin, Kathleen M Giacomini,[...]. Protein Sci 2010
78
25

Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer.
Junliang Li, Fangqiu Fu, Xuechao Wan, Shengsong Huang, Denglong Wu, Yao Li. Gene 2018
21
25

CircRUNX1 functions as an oncogene in colorectal cancer by regulating circRUNX1/miR-485-5p/SLC38A1 axis.
Juan Yu, Xiaoguang Chen, Jing Li, Furang Wang. Eur J Clin Invest 2021
4
25

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
Ai-Ming Yu, Young Hee Choi, Mei-Juan Tu. Pharmacol Rev 2020
95
25

Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
Xiaoguang Liu, Kellen Olszewski, Yilei Zhang, Esther W Lim, Jiejun Shi, Xiaoshan Zhang, Jie Zhang, Hyemin Lee, Pranavi Koppula, Guang Lei,[...]. Nat Cell Biol 2020
87
25


Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.
Jason W Locasale, Alexandra R Grassian, Tamar Melman, Costas A Lyssiotis, Katherine R Mattaini, Adam J Bass, Gregory Heffron, Christian M Metallo, Taru Muranen, Hadar Sharfi,[...]. Nat Genet 2011
747
25

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
David S Hong, Yoon-Koo Kang, Mitesh Borad, Jasgit Sachdev, Samuel Ejadi, Ho Yeong Lim, Andrew J Brenner, Keunchil Park, Jae-Lyun Lee, Tae-You Kim,[...]. Br J Cancer 2020
243
25

The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.
Jan Lewerenz, Sandra J Hewett, Ying Huang, Maria Lambros, Peter W Gout, Peter W Kalivas, Ann Massie, Ilse Smolders, Axel Methner, Mathias Pergande,[...]. Antioxid Redox Signal 2013
497
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.